Insight certainty 3/5 debate potential 2/5

Liu: Generative AI in science makes validation much harder than idea generation

Bowen Liu · AI at the Intersection of Bio | Vijay Pande, Surya Ganguli & Bowen Liu · Oct 3, 2024 · at 12:52

Bowen Liu, an investment partner at a16z, contrasts generative AI models in consumer media with their application in scientific domains like drug design.

0:00 / 0:07exact quote · 7.8s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“In science, you know, it's actually the inverse. Like, it's actually, it's probably easier to generate ideas, but way harder to validate.”

quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →

More from Bowen Liu

Assertion Not checkable as stated
Liu: Protein structure prediction is essentially solved for many common proteins
“In the past, like, four or five years, this problem of protein structure prediction went from, you know, something that was, you know, quite far away from being solved, to now you could argue that, It's pretty much been solved for a lot of, like, common kind o…”
Bowen Liu Oct 3, 2024 ▶ 8:20 AI at the Intersection of Bio | Vijay Pande, Surya Ganguli & Bowen Liu
Assertion Not checkable as stated
Bowen Liu calls labeled data scarcity the core bottleneck in scientific AI
“Yeah, I think you touched on, like, probably the core problem of, like, you know, ML applied to science. While we have a lot of, like, unlabeled data, like, there's just not that much label data out there. And a lot of it is because, like, it's very experiment…”
Bowen Liu Oct 3, 2024 ▶ 7:09 AI at the Intersection of Bio | Vijay Pande, Surya Ganguli & Bowen Liu
Assertion Not checkable as stated
Bowen Liu: Small Molecules Currently Lack Self-Supervised Learning Frameworks
“Because like with protein sequences and biological sequences, like you can actually do self-supervised learning, right? Because there is this like complicated generative process with like evolutionary pressure that you can learn from. There's no equivalent for…”
Bowen Liu Oct 3, 2024 ▶ 18:05 AI at the Intersection of Bio | Vijay Pande, Surya Ganguli & Bowen Liu
Assertion Not checkable as stated
Liu: 100 active compounds is a drug candidate but tiny for ML
“Usually in a drug discovery project, you know, if you have a hundred actives, you should be close to a drug, but a hundred data points is, like, tiny for machine learning, right?”
Bowen Liu Oct 3, 2024 ▶ 7:28 AI at the Intersection of Bio | Vijay Pande, Surya Ganguli & Bowen Liu
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.